Trials / Completed
CompletedNCT02486939
A Long Term Safety Extension Study (CHS-0214-05)
An Open-Label Safety Extension Study (OLSES) Evaluating the Long Term Safety and Durability of Response of CHS-0214 (CHS-0214-05)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 359 (actual)
- Sponsor
- Coherus Oncology, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
An Open-label, Safety Extension Study (OLSES) evaluating the longer-term safety and durability of response of subjects who completed 48 weeks of evaluations in the confirmatory safety and efficacy studies, CHS 0214-02 or CHS-0214-04, evaluating CHS-0214 in patients with rheumatoid arthritis (RA) and plaque psoriasis (PsO), respectively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CHS-0214 | Open label |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2017-09-01
- Completion
- 2017-10-01
- First posted
- 2015-07-01
- Last updated
- 2018-12-27
- Results posted
- 2018-12-27
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02486939. Inclusion in this directory is not an endorsement.